GLOOM
-
caregiver burden, Chinese American caregivers, cultural adaptation, dementia caregivers, dementia stigma, family counseling, KakaoTalk, Korean American caregivers, Neurodegenerative Diseases, NYUCI-ES, Psychiatry, Psychology, therapy, TIDieR, WeChatDementia Caregiver Intervention Needed 24 Cultural Adaptations
A 2026 descriptive study documented 24 major cultural adaptations to the New…
-
A4 study, ADNI, Alzheimer’s disease, amyloid PET, blood biomarker, Brain, calibration, cognition, machine learning, negative predictive value, Neurodegenerative Diseases, p-tau217, plasma biomarkersAlzheimer’s Blood Biomarker Models Lose Rule-Out Power Across Cohorts
A 2026 ADNI/A4 validation study found that Alzheimer’s plasma-biomarker machine-learning models still…
-
acute repetitive seizures, Brain, brivaracetam, epilepsy, focal epilepsy, intranasal medication, levetiracetam, neuroscience, non-benzodiazepine rescue, photosensitive epilepsy, seizure rescue therapy, seletracetam, SV2A, therapySeletracetam for Seizure Rescue: Non-Benzodiazepine Alternative Revisited
A 2026 CNS Drugs review argues that seletracetam, an abandoned second-generation racetam…
-
3-PBA, depression, depression risk, environmental exposure, household pesticides, NHANES, PHQ-9, Psychiatry, Psychology, pyrethroidsHousehold Pesticide 3-PBA Linked to Depression Risk in 6,502 Adults
A 2026 NHANES analysis of 6,502 adults found that urinary 3-PBA, a…
-
Autism, Brain, cortical folding, developing Human Connectome Project, functional connectivity, gyri, neonatal brain development, neonatal MRI, neurodevelopment, neuroscience, schizophrenia, structural connectivity, structure-function coupling, sulciNeonatal Brain MRI Shows Gyri Are Connectivity Hubs by 38-44 Weeks
A 2026 developing Human Connectome Project analysis of 438 full-term neonates found…
-
A-beta 42/40, Alzheimer’s disease, amyloid PET, blood biomarkers, Brain, Clarity AD, cognition, GFAP, lecanemab, maintenance dosing, Neurodegenerative Diseases, p-tau181, PK/PD modelingLecanemab Blood Biomarkers Rebound Faster Than Amyloid PET After Stopping
Lecanemab blood biomarkers may rebound much faster than amyloid PET after treatment…
-
Brain, cognition, cognitive impairment, CPAP, dementia risk, Epworth Sleepiness Scale, excessive daytime sleepiness, memory, Neurodegenerative Diseases, obstructive sleep apnea, osa, PAP therapy, pitolisant, Psychomotor Vigilance Task, sleep, solriamfetolResidual Sleepiness in Treated Sleep Apnea Linked to Memory Deficits
Some sleep apnea patients stay sleepy even when their CPAP is used…
-
ACE study, adulthood adversity, biological aging, Brain, childhood adversity, cognition, frailty index, grip strength, longitudinal cohort, metabolomics, MileAge, Psychiatry, Psychology, Stress, telomere length, trauma, UK BiobankChild and Adult Adversity Doubled Frailty in UK Biobank
A 2026 UK Biobank analysis by Aas et al. in BMC Medicine…
-
artificial-intelligence, Brain, digital health, dyskinesia, feasibility trial, levodopa, medication adherence, neuroscience, parkinson’s disease, UPDRS, wearing offAI Levodopa Timing Improved UPDRS 4.4 Points in 5 Parkinson Patients
A 2026 open-label feasibility trial involving 5 Parkinson’s disease patients found that…
-
Brain, brain tumor, fMRI, glioma surgery, language mapping, language network, Neuromodulation, neuroplasticity, neuroscience, Neurostimulation, non-invasive prehabilitation, transcranial direct current stimulation, Transcranial Magnetic StimulationNon-Invasive Prehabilitation Shifted Brain Tumor Language Networks
A 2026 brain tumor prehabilitation study involving 26 surgical patients found that…
